Standout Papers

Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorecta... 2005 2026 2012 2019 694
  1. Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial (2005)
    Fairooz F. Kabbinavar, Joseph J. Schulz et al. Journal of Clinical Oncology

Immediate Impact

6 from Science/Nature 87 standout
Sub-graph 1 of 19

Citing Papers

Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
2023 Standout
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
2023 Standout
2 intermediate papers

Works of B. Nelson being referenced

Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial
2005 Standout

Author Peers

Author Last Decade Papers Cites
B. Nelson 774 163 285 274 11 1000
Frédérique Maindrault‐Gœbel 740 139 139 290 14 939
Seta Shahin 794 102 120 315 13 925
A. Misino 735 131 131 357 25 955
G Paoletti 757 149 128 342 28 944
Sanjaykumar Hapani 564 154 215 358 9 1.0k
D Larregain-Fournier 917 261 141 253 8 1.1k
Karen Rittweger 947 269 134 359 17 1.3k
Hiroomi Tada 527 114 361 390 13 936
Tarek Chidiac 783 95 202 378 16 985
Garry Forgeson 485 168 191 223 22 900

All Works

Loading papers...

Rankless by CCL
2026